Summary of Case and Settlement: Case No. 00-CV-6222 (E.D. Pa.). In four consolidate actions, Plaintiffs alleged that SmithKline, which makes the brand-name antidepressant Paxil, misled the United States Patent Office into issuing patents to protect Paxil from competition from generic substitutes. On April 22, 2005, Judge John R. Padova granted final approval to a $65 million class action settlement for the benefit of consumers and third-party payors who paid for Paxil. Nichols v. SmithKline Beecham Corp., 2005-1 Trade Cas. (CCH) ¶74,762 (E.D. Pa. April 22, 2005). See also Nichols v. SmithKline Beecham Corp., 2003 WL 302352 2003-1 Trade Cas. (CCH) ¶ 73,974 (E.D. Pa. Jan. 29, 2003) (denying defendant’s motion to strike expert testimony).
Contact Us For More Information: If you would like to receive additional information on the settlement, please click here: click here